Back to top
Rydex Series Fds, Biotechnology Fund H Class: (MF: RYOAX)
(NASDAQ Mutual Funds) As of Jul 16, 2025 08:00 PM ET
$53.11 USD
+0.94 (1.80%)
Zacks MF Rank
4-Sell of 5 4
Latest Performance as of Jun 30, 2025
| Total Return %* | Percentile Rank Objective | |
|---|---|---|
| YTD | -1.58 | 33 |
| 3 months | -0.17 | 23 |
| 6 months | -1.58 | 33 |
| 1 Year | -5.19 | 33 |
| 3 Year | 3.44 | 60 |
| 5 Year | 0.22 | 85 |
| 10 Year | 1.42 | 89 |
* Annual for three years and beyond.
| Bull Market (9/02 - 10/07) | 88.68 |
| Bear Market (10/07 - 2/09) | -26.94 |
| Bull Market (2/09 - 3/21) | 538.08 |
Load Adjusted Returns as of Jun 30, 2025
| 1 Year | -5.19 |
| 5 Year | 0.21 |
| 10 Year | 1.43 |
| Since Inception | 9.36 |
Quarterly Return
| 1st Qtr. | 2nd Qtr. | 3rd Qtr. | 4th Qtr. | |
|---|---|---|---|---|
| 2025 | -1.41 | -0.17 | NA | NA |
| 2024 | 0.73 | 2.02 | 4.84 | -8.10 |
| 2023 | -2.24 | 0.03 | -3.90 | 12.58 |
| 2022 | -9.93 | -10.29 | -2.20 | 9.76 |
| 2021 | -1.60 | 10.00 | -3.24 | -3.02 |
| 2020 | -14.68 | 28.19 | 0.41 | 10.88 |
Annual Return
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| % Total Return | -1.58 | -0.98 | 5.80 | -13.27 | 1.56 | 21.78 | 24.69 | -9.21 | 29.43 | -19.72 | 8.39 |
| % Total Return Rel to Index | -7.79 | -26.00 | -20.44 | 4.92 | -27.12 | 3.37 | -6.79 | -4.82 | 7.64 | -31.66 | 7.00 |
| % Total Return Rel to Peer | 1.33 | -3.60 | 0.03 | -3.86 | -7.12 | 0.50 | -1.98 | -9.34 | 7.31 | -8.94 | 0.96 |
| % Perf Quintile vs Peer* | 0.00 | 0.00 | 3.00 | 4.00 | 5.00 | 3.00 | 4.00 | 5.00 | 2.00 | 5.00 | 3.00 |
| % Dividends | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| % Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Gains ($) | 0.00 | 9.42 | 0.00 | 0.90 | 15.77 | 6.95 | 3.60 | 9.88 | 4.70 | 0.00 | 1.28 |
| Expense Ratio | 1.64 | 1.65 | 1.64 | 1.61 | 1.72 | 1.73 | 1.71 | 1.62 | 1.61 | 1.65 | 1.83 |
* 1 = Top 20%, 5 = Bottom 20%